Clinical Trials Directory

Trials / Unknown

UnknownNCT04941547

Association Between Cancer and Anti-synthetase Syndrome

Association Between Cancer and Anti-synthetase Syndrome : a Multicenter Study

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Among Idiopathic inflammatory myopathies, antisynthetase syndrome is meant to be rarely associated with cancer. However, clinical evidences of the association of those diseases led to the hypothesis that previous studies might have underestimated the prevalence of cancer in patients with antisynthetase syndrome. The aim of this study was to assess the prevalence of cancer in patients with antisynthetases syndrome in Grand Est and Bourgogne Franche-Comté regions.

Detailed description

Idiopathic inflammatory myopathies area heterogeneous group of disease involving mainly muscles, which paraneoplastic feature has been well characterized, specifically in some subgroups such as dermatomyositis. In contrast, antisynthetase syndrome is thought to be rarely associated with cancer. However, clinical observations of the association of those diseases led us to the hypothesis that previous studies might have underestimated the prevalence of cancer in patients with antisynthetase syndrome. The aim of this study was to assess the prevalence of cancer in patients with antisynthetases syndrome in Grand Est and Bourgogne Franche-Comté regions, describing the type of cancer observed as well as clinical features of patients and diagnostic work-up leading to the diagnosis of cancer.

Conditions

Timeline

Start date
2021-04-01
Primary completion
2021-07-31
Completion
2021-09-01
First posted
2021-06-28
Last updated
2021-06-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04941547. Inclusion in this directory is not an endorsement.